NasdaqGS - Delayed Quote USD
IDEAYA Biosciences, Inc. (IDYA)
At close: October 18 at 4:00 PM EDT
Environment, Social and Governance (ESG) Risk Ratings
Total ESG Risk Score
33.7
ESG Risk Score for Peers
| Name | Total ESG Risk score | E | S | G |
|---|---|---|---|---|
| PHAT Phathom Pharmaceuticals, Inc. | 34 | -- | -- | -- |
| RVMD Revolution Medicines, Inc. | 34 | -- | -- | -- |
| IDYA IDEAYA Biosciences, Inc. | 34 | -- | -- | -- |
| OLMA Olema Pharmaceuticals, Inc. | 34 | -- | -- | -- |
| CHJTF CSPC PHARMACEUTICAL GROUP LIMIT | 34 | 4 | 18 | 12 |
Controversy Level Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies are rated on a scale from one to five with five denoting the most serious controversies with the largest potential impact.
Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies are rated on a scale from one to five with five denoting the most serious controversies with the largest potential impact.
ESG data provided by Sustainalytics, Inc. Last Updated on 10/2024
IDYA
Category Average
N/A None Controversy Level
None 4 Severe
-- IDYA
0.4 Category Average
Product Involvement Areas Flags a company’s involvement in products, services and business activities commonly used for screening purposes.
Flags a company’s involvement in products, services and business activities commonly used for screening purposes.
| Products and Activities | Significant Involvement |
|---|---|
| Alcoholic Beverages | No |
| Adult Entertainment | No |
| Gambling | No |
| Tobacco Products | No |
| Animal Testing | Yes |
| Fur and Specialty Leather | No |
| Controversial Weapons | No |
| Small Arms | No |
| Catholic Values | No |
| GMO | No |
| Military Contracting | No |
| Pesticides | No |
| Thermal Coal | No |
| Palm Oil | No |
Related Tickers
MRUS Merus N.V.
52.69
+1.84%
PTGX Protagonist Therapeutics, Inc.
46.97
-0.11%
KROS Keros Therapeutics, Inc.
61.25
+0.26%
SYRE Spyre Therapeutics, Inc.
32.76
0.00%
MLTX MoonLake Immunotherapeutics
48.94
+1.79%
TNGX Tango Therapeutics, Inc.
7.46
+6.57%
KRYS Krystal Biotech, Inc.
179.19
+1.34%
NRIX Nurix Therapeutics, Inc.
25.05
+1.33%
SWTX SpringWorks Therapeutics, Inc.
30.97
+0.62%
IMVT Immunovant, Inc.
29.47
+0.72%